(Q37774697)

23 August 2017

1 reference

title

Advanced glycation end-products and the kidney (English)

1 reference

23 August 2017

Martin Busch

1

1 reference

23 August 2017

Sybille Franke

series ordinal

2

1 reference

23 August 2017

Christiane Rüster

series ordinal

3

1 reference

23 August 2017

Gunter Wolf

series ordinal

4

1 reference

23 August 2017

language of work or name

1 reference

1 August 2010

1 reference

European Journal of Clinical Investigation

23 August 2017

published in

1 reference

23 August 2017

volume

40

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

742-755

1 reference

New biomarkers of Maillard reaction damage to proteins

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02317.X

10.1111/J.1365-2362.2010.02317.X

21 January 2018

Identifiers

DOI

1 reference

release_kv7ibsthwnhgxj7hare4ylaipy

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kv7ibsthwnhgxj7hare4ylaipy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference